PAK4 inhibition augments anti-tumour effect by immunomodulation in oral squamous cell carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
PAK4 inhibition augments anti-tumour effect by immunomodulation in oral squamous cell carcinoma ; volume:14 ; number:1 ; day:18 ; month:6 ; year:2024 ; pages:1-14 ; date:12.2024
Scientific reports ; 14, Heft 1 (18.6.2024), 1-14, 12.2024
- Urheber
-
Takatsuka, Danki
Tachinami, Hidetake
Suzuki, Nihei
Yamazaki, Manabu
Yonesi, Amirmoezz
Takaichi, Mayu
Imaue, Shuichi
Yamada, Shin-Ichi
Tanuma, Jun-Ichi
Noguchi, Makoto
Tomihara, Kei
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-64126-0
- URN
-
urn:nbn:de:101:1-2409110947587.275173408011
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Takatsuka, Danki
- Tachinami, Hidetake
- Suzuki, Nihei
- Yamazaki, Manabu
- Yonesi, Amirmoezz
- Takaichi, Mayu
- Imaue, Shuichi
- Yamada, Shin-Ichi
- Tanuma, Jun-Ichi
- Noguchi, Makoto
- Tomihara, Kei
- SpringerLink (Online service)
Ähnliche Objekte (12)
Acid affairs in anti-tumour immunity
Anti-tumour activity of Panobinostat in oesophageal adenocarcinoma and squamous cell carcinoma cell lines
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Glutarate regulates T cell metabolism and anti-tumour immunity
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy
A review of anti-tumour effects of Ganoderma lucidum in gastrointestinal cancer
Acid affairs in anti-tumour immunity
Anti-tumour activity of Panobinostat in oesophageal adenocarcinoma and squamous cell carcinoma cell lines
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Glutarate regulates T cell metabolism and anti-tumour immunity
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy
A review of anti-tumour effects of Ganoderma lucidum in gastrointestinal cancer
Acid affairs in anti-tumour immunity
Anti-tumour activity of Panobinostat in oesophageal adenocarcinoma and squamous cell carcinoma cell lines
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Glutarate regulates T cell metabolism and anti-tumour immunity
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy